Member Daniel Cody shared key insights at the Digital Therapeutics Alliance conference, as covered in Fierce Healthcare.

Dan advised digital therapeutics companies to recognize the existence of easier regulatory pathways. He gave the current state of the industry a “B-”, noting that the investment landscape is not as robust as a few years ago, with current macroeconomic factors making it difficult to secure investments.

Source

Fierce Healthcare